Monday, January 3, 2022

FDA Significantly Increases Pfizer Vaccine Emergency Use Authorization -- January 3, 2022

Link here.

  • Expand the use of a single booster dose to include use in individuals 12 through 15 years of age.
  • Shorten the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 Vaccine and a booster dose to at least five months.
  • Allow for a third primary series dose for certain immunocompromised children 5 through 11 years of age.

***************************
The Bat Cave

Weather folks said it was going to be freezing this week. Well, perhaps not so much.

We're in the "bat cave" today and it's almost perfect.